Q this, and thanks for, um, not turning this into a product pitch, which is something I typically ask people to do, but they don't always do that. Um, could, but so, since you've been so kind from that, um, perspective, could you actually, uh, tell us a little bit more about what, uh, Recommend actually does, just, you know, in a, in a minute, the, the first product in particular?
A Absolutely. So I mentioned single gene disorders like cystic fibrosis. Those are actually regularly tested for in the U.S. by either fertility physician, reproductive endocrinologists, or OBGYNs. Um, LabCorp and Quest, two of the two biggest labs, dominate that testing market, um, and each disease that you might test for, cystic fibrosis, spinal muscular atrophy, Fragile X, Tay-Sachs, these are well-known diseases, can cost thousands of dollars using older technologies, so the first thing we did actually is apply these microarray and sequencing technologies, and we developed a test that can do 250 of the most common diseases of this nature for under 500 dollars to patients that don't have private insurance, and This is just making it more accessible. It's generating more data. It's more accurate. It's faster. It's really an application of these technologies to an area that we're already regularly doing in medicine, um, and beyond that, what we can do now is we can leverage the amount of data we're generating at the point of care and actually run research and development and become an asset for our physicians, so, um.
AI assessment note: “we developed a test that can do 250 of the most common diseases”